Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000724394> ?p ?o ?g. }
- W2000724394 endingPage "626" @default.
- W2000724394 startingPage "620" @default.
- W2000724394 abstract "Abstract Background & Aims The benefits of combined systemic and liver‐directed treatments in inoperable intermediate‐ or advanced‐stage hepatocellular carcinoma ( HCC ) have yet to be defined. This article presents the planned safety analyses for the first 40 patients randomized to radioembolization with yttrium‐90 ( 90 Y) resin microspheres followed by sorafenib ( n = 20) or sorafenib only ( n = 20) in the SORAMIC study. Methods Patients identified for palliative treatment who were poor candidates for transarterial (chemo)embolization (including those failing TACE ) with preserved liver function (Child–Pugh ≤B7) and ECOG performance status <2 were screened. Radioembolization was administered using a sequential lobar approach. On day 3 after the last radioembolization procedure, sorafenib 200 mg twice daily was initiated escalating to 400 mg twice daily 1 week later; a matching sorafenib dose schedule was initiated in the control arm. Results Patients were followed up for a median of 8.3 months. Median total implanted activity of 90 Y was 1.87 (range: 0.54–2.35) GB q. Patients received a similar intensity and duration of sorafenib in the combination‐treatment arm (median daily dose 614 mg over 8.5 months) and control arm (557 mg over 9.6 months). The incidence of total (196 vs. 222) and grade ≥3 (43 vs. 47) adverse events was similar in combination‐treatment arm and control arm respectively ( P > 0.05). No significant differences in the number of total or grade 3/4 toxicities were recorded for: total bilirubin, albumin, liver enzymes, ascites, Child–Pugh, fatigue, hand–foot skin reaction, blood pressure or diarrhoea. Conclusions Radioembolization followed by sorafenib appears to be as well tolerated as sorafenib alone." @default.
- W2000724394 created "2016-06-24" @default.
- W2000724394 creator A5001010553 @default.
- W2000724394 creator A5003801134 @default.
- W2000724394 creator A5012255962 @default.
- W2000724394 creator A5035873897 @default.
- W2000724394 creator A5042318267 @default.
- W2000724394 creator A5048446588 @default.
- W2000724394 creator A5057700552 @default.
- W2000724394 creator A5071739593 @default.
- W2000724394 creator A5073821908 @default.
- W2000724394 creator A5073880705 @default.
- W2000724394 creator A5085766415 @default.
- W2000724394 date "2014-07-08" @default.
- W2000724394 modified "2023-10-15" @default.
- W2000724394 title "Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC" @default.
- W2000724394 cites W1528535414 @default.
- W2000724394 cites W1971837077 @default.
- W2000724394 cites W1975154077 @default.
- W2000724394 cites W1976208893 @default.
- W2000724394 cites W1984101482 @default.
- W2000724394 cites W1990295946 @default.
- W2000724394 cites W1994193851 @default.
- W2000724394 cites W1998417832 @default.
- W2000724394 cites W2037501213 @default.
- W2000724394 cites W2040474372 @default.
- W2000724394 cites W2046516248 @default.
- W2000724394 cites W2051842222 @default.
- W2000724394 cites W2057153015 @default.
- W2000724394 cites W2058544933 @default.
- W2000724394 cites W2058636642 @default.
- W2000724394 cites W2066593706 @default.
- W2000724394 cites W2088974189 @default.
- W2000724394 cites W2109712769 @default.
- W2000724394 cites W2128125049 @default.
- W2000724394 cites W2169246379 @default.
- W2000724394 cites W4243372305 @default.
- W2000724394 cites W4245784696 @default.
- W2000724394 doi "https://doi.org/10.1111/liv.12622" @default.
- W2000724394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24930619" @default.
- W2000724394 hasPublicationYear "2014" @default.
- W2000724394 type Work @default.
- W2000724394 sameAs 2000724394 @default.
- W2000724394 citedByCount "72" @default.
- W2000724394 countsByYear W20007243942014 @default.
- W2000724394 countsByYear W20007243942015 @default.
- W2000724394 countsByYear W20007243942016 @default.
- W2000724394 countsByYear W20007243942017 @default.
- W2000724394 countsByYear W20007243942018 @default.
- W2000724394 countsByYear W20007243942019 @default.
- W2000724394 countsByYear W20007243942020 @default.
- W2000724394 countsByYear W20007243942021 @default.
- W2000724394 countsByYear W20007243942022 @default.
- W2000724394 crossrefType "journal-article" @default.
- W2000724394 hasAuthorship W2000724394A5001010553 @default.
- W2000724394 hasAuthorship W2000724394A5003801134 @default.
- W2000724394 hasAuthorship W2000724394A5012255962 @default.
- W2000724394 hasAuthorship W2000724394A5035873897 @default.
- W2000724394 hasAuthorship W2000724394A5042318267 @default.
- W2000724394 hasAuthorship W2000724394A5048446588 @default.
- W2000724394 hasAuthorship W2000724394A5057700552 @default.
- W2000724394 hasAuthorship W2000724394A5071739593 @default.
- W2000724394 hasAuthorship W2000724394A5073821908 @default.
- W2000724394 hasAuthorship W2000724394A5073880705 @default.
- W2000724394 hasAuthorship W2000724394A5085766415 @default.
- W2000724394 hasConcept C126322002 @default.
- W2000724394 hasConcept C141071460 @default.
- W2000724394 hasConcept C197934379 @default.
- W2000724394 hasConcept C2778019345 @default.
- W2000724394 hasConcept C2778695046 @default.
- W2000724394 hasConcept C2779185275 @default.
- W2000724394 hasConcept C2780496750 @default.
- W2000724394 hasConcept C29730261 @default.
- W2000724394 hasConcept C2992208098 @default.
- W2000724394 hasConcept C71924100 @default.
- W2000724394 hasConcept C90924648 @default.
- W2000724394 hasConceptScore W2000724394C126322002 @default.
- W2000724394 hasConceptScore W2000724394C141071460 @default.
- W2000724394 hasConceptScore W2000724394C197934379 @default.
- W2000724394 hasConceptScore W2000724394C2778019345 @default.
- W2000724394 hasConceptScore W2000724394C2778695046 @default.
- W2000724394 hasConceptScore W2000724394C2779185275 @default.
- W2000724394 hasConceptScore W2000724394C2780496750 @default.
- W2000724394 hasConceptScore W2000724394C29730261 @default.
- W2000724394 hasConceptScore W2000724394C2992208098 @default.
- W2000724394 hasConceptScore W2000724394C71924100 @default.
- W2000724394 hasConceptScore W2000724394C90924648 @default.
- W2000724394 hasFunder F4320320303 @default.
- W2000724394 hasFunder F4320330066 @default.
- W2000724394 hasIssue "2" @default.
- W2000724394 hasLocation W20007243941 @default.
- W2000724394 hasLocation W20007243942 @default.
- W2000724394 hasOpenAccess W2000724394 @default.
- W2000724394 hasPrimaryLocation W20007243941 @default.
- W2000724394 hasRelatedWork W1990960836 @default.
- W2000724394 hasRelatedWork W2378315152 @default.
- W2000724394 hasRelatedWork W2381257096 @default.
- W2000724394 hasRelatedWork W2466156289 @default.